CD103+ CD8 T Cells in the Toxoplasma-Infected Brain Exhibit a Tissue-Resident Memory Transcriptional Profile by Tyler A. Landrith et al.
March 2017 | Volume 8 | Article 3351
Original research
published: 29 March 2017
doi: 10.3389/fimmu.2017.00335
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Jason Paul Gigley, 
University of Wyoming, USA
Reviewed by: 
David Gondek, 
Ithaca College, USA  
Karina Pino-Lagos, 
University of the Andes Chile, Chile
*Correspondence:
Emma H. Wilson 
emma.wilson@ucr.edu
Specialty section: 
This article was submitted to 
Microbial Immunology, 







Rivera A, Jang JC, Rais M, Nair MG, 
Messaoudi I and Wilson EH (2017) 
CD103+ CD8 T Cells in the 
Toxoplasma-Infected Brain Exhibit 
a Tissue-Resident Memory 
Transcriptional Profile. 
Front. Immunol. 8:335. 
doi: 10.3389/fimmu.2017.00335
cD103+ cD8 T cells in the 
Toxoplasma-infected Brain exhibit  
a Tissue-resident Memory 
Transcriptional Profile
Tyler A. Landrith, Suhas Sureshchandra, Andrea Rivera, Jessica C. Jang, Maham Rais, 
Meera G. Nair, Ilhem Messaoudi and Emma H. Wilson*
School of Medicine, University of California, Riverside, CA, USA
During chronic infection, memory T  cells acquire a unique phenotype and become 
dependent on different survival signals than those needed for memory T cells generated 
during an acute infection. The distinction between the role of effector and memory T cells 
in an environment of persistent antigen remains unclear. Here, in the context of chronic 
Toxoplasma gondii infection, we demonstrate that a population of CD8 T cells exhibiting 
a tissue-resident memory (TRM) phenotype accumulates within the brain. We show that 
this population is distributed throughout the brain in both parenchymal and extraparen-
chymal spaces. Furthermore, this population is transcriptionally distinct and exhibits a 
transcriptional signature consistent with the TRM observed in acute viral infections. Finally, 
we establish that the CD103+ TRM population has an intrinsic capacity to produce both 
IFN-γ and TNF-α, cytokines critical for parasite control within the central nervous system 
(CNS). The contribution of this population to pro-inflammatory cytokine production 
suggests an important role for TRM in protective and ongoing immune responses in the 
infected CNS.
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inTrODUcTiOn
Persistent infections in the brain present an especially daunting challenge for the immune response 
due to the unique set of rules governing entry of peripheral cells and molecules into this tissue (1). 
Immune surveillance of the brain occurs entirely in the cerebrospinal fluid, and T cell infiltration into 
the parenchyma occurs only during injury and inflammation (2–4). During chronic infection with 
the intracellular protozoan parasite Toxoplasma gondii, there is a well-regulated protective response 
within the brain mediated by infiltrating T cells, which are required to prevent fatal reactivation (5). 
This continuous recruitment and the presence of activated CD4+ and CD8+ T cells in the central 
nervous system (CNS) represent the generation of protective immunity for the host, but fail to clear 
the parasite, which continues to reside as cysts within neurons (5, 6). The basis and composition of 
the long-term protective T cell response in the brain remains an active area of research.
Although protection could be mediated in part by a continuous pool of effector cells, there is 
also evidence of the involvement of memory T cell subsets (1, 7–9). Mice chronically infected with 
T. gondii exhibit protection against challenge with the virulent RH strain of the parasite, which is 
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lethal in naïve mice (10). Persisting antigen is not required for 
such protection as infection of mice with attenuated strains of T. 
gondii confers protection upon rechallenge (10, 11). This suggests 
that the memory populations generated during chronic T. gondii 
infection are indeed functional, but it is unclear whether there is 
a distinction in the protection afforded by effector and memory 
T  cell subsets in an environment of persistent antigen. Several 
subsets of memory T cells have been established, including cen-
tral memory, effector memory, and tissue-resident memory (TRM) 
cells (12, 13). During chronic infection, memory T cells require 
unique survival signals (14) and can acquire distinct phenotypes, 
including an exhausted/attenuated phenotype (15). In chronic T. 
gondii infection, the recent discovery of a T  cell population in 
an intermediate state (TINT) between memory and effector status 
provides an important clue to understanding the coordination 
of the T  cell response in this context (9). Nevertheless, during 
chronic infection, the unique role for a memory response as 
opposed to the effector response remains undefined.
The location of the parasite in the parenchyma of the brain 
offers a potential role for TRM cells in protection against parasite 
reactivation. TRM cells have been implicated in the recruit-
ment of peripheral lymphocytes and dendritic cell activation/
maturation via secretion of pro-inflammatory cytokines and 
chemokines (16, 17). The TRM population is characterized by 
expression of the activation marker CD69, which in tandem 
with the suppression of the tissue egress axis KLF2/S1PR1, 
ensures TRM do not recirculate and remain localized in the 
tissue. Although not expressed by all TRM, the expression of 
the integrin CD103 is a defining marker of tissue residency. 
Typically, CD103 tethers TRM to epithelial tissues through 
binding to its ligand E-cadherin (18, 19). This positions these 
cells optimally for a sensing and alarm function at the site of 
infection (16, 17, 20, 21), suggesting that this memory T  cell 
subset is critical for a first-line protective response to localized 
infection. Much of the work on TRM has been accomplished 
by studying acute infection models (22–26) where infection 
is resolved and antigen is cleared. This includes viral infection 
in the CNS (23) and parasitic challenge in the skin and liver 
(27, 28). Indeed, memory is frequently defined as persistent cells 
in the absence of infection. Yet during Toxoplasma infection, we 
observed a significant population of CD103+ cells in the brain. 
This provoked the question of whether the expression of CD103 
defined a TRM population during chronic infection of the CNS or 
whether it represented transient expression by a more common 
effector population.
Here, we show that a population with a TRM phenotype 
(CD8+ CD69+ CD103+) exists in the brain during the chronic 
stage of infection, and such a population is not confined to 
endothelial tissues but is observed throughout the brain. In our 
model, expression of CD103 defines a transcriptionally distinct 
population that is consistent with the established literature on TRM 
(23, 25). Furthermore, this population has a significantly greater 
capacity to produce the pro-inflammatory cytokines TNF-α and 
IFN-γ. Thus, even in the context of continuous antigen exposure, 
recruitment, and exhaustion of effector cells, there exists a 
population of CD8+ CD103+ T cells that exhibit a transcriptional 
profile characteristic of TRM. Their generation alone is not clearly 
sufficient to eliminate a chronic parasitic infection from the brain 
but may be critical nevertheless for host protective immunity.
Therefore, the presence of a population of TRM during T. gondii 
infection is relevant not only to the immune response against the 
parasite at this stage but also to more fundamental questions 
regarding the role of TRM and other memory subsets during 
chronic infection where significant antigen persists.
MaTerials anD MeThODs
Mice and Parasites
Two type II strains of Toxoplasma were used to allow the quan-
tification of parasite-specific T cells and to maximize the ability 
to see cysts in the brain. First, a strain engineered to secrete 
ovalbumin (Pru-OVA) (29) was maintained in  vitro in human 
foreskin fibroblasts (HFF) grown in complete DMEM (90% 
DMEM, 10% fetal bovine serum, 1% penicillin/streptomycin). 
After infecting HFFs, parasites were grown in D10 media (70% 
DMEM, 20% M199, 10% fetal bovine serum, 5% penicillin/
streptomycin, 5% gentamycin) with chloramphenicol. Parasites 
were purified for infection by passage through a 22.5-gauge 
needle followed by passage through a 5.0-mm nylon filter. After 
centrifugation at ~2,000 ×  g for 10  min at 4°C, parasites were 
counted and resuspended in an appropriate volume of 1× PBS. 
Ten thousand tachyzoites were intraperitoneally (i.p.) injected in 
200 µL PBS. Second, the Me49 strain of parasites was maintained 
in CBA mice. For infections, brains were harvested from chroni-
cally infected mice and homogenized in 3 mL of PBS by needle 
passage. After counting, cysts were resuspended in an appropriate 
volume of PBS to infect i.p. at 20 cysts per mouse in a 200 µL 
volume. C57Bl/6 and CBA mice were obtained from the Jackson 
Laboratory (Jackson ImmunoResearch Laboratories, Inc., West 
Grove, PA, USA). Mice were maintained in a pathogen-free envi-
ronment under IACUC established protocols at the University of 
California, Riverside.
Flow cytometry
Before harvest, mice were intracardially perfused with 20  mL 
ice-cold PBS, with perfusion confirmed by the white appearance 
of the brain and lack of red blood cells during tissue processing. 
Mononuclear cells were isolated from the brain by mincing and 
subsequent homogenization via passage through an 18-gauge 
needle in complete RPMI (86% RPMI, 10% FBS, 1% penicillin/
streptomycin, 1% l-glutamine, 1% NEAA, 1% sodium pyruvate 
<0.01% β-mercaptoethanol). The resulting suspension was 
incubated at 37°C with 3 mg DNAse and 100 µg collagenase for 
1  h and 45  min. After incubation, the suspension was passed 
through a 70-µm strainer, and mononuclear cells were isolated 
using a density gradient spun at 2,000 rpm for 25 min with no 
brakes. The density gradient consisted of a 60% Percoll solution 
in cRPMI overlayed with a 30% Percoll solution in PBS. Brain 
mononuclear cells (BMNCs) were isolated from the interphase, 
counted and washed in FACS buffer, blocked for 10 min in Fc block 
(BD Biosciences), and then incubated with a panel of antibodies 
against CD3, CD8, CD4, CD69, and CD103 (eBioscience) for 
30 min protected from light. Samples were then washed and fixed 
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in 4% PFA. Dextramer staining was performed as follows: Prior to 
surface staining, samples were incubated with ovalbumin-specific 
(SIINKFEKL) MHC I dextramer (Immudex) at room tempera-
ture for 45 min, protected from light. The finished samples were 
resuspended in FACS buffer and analyzed using a FACS Canto 
from BD Biosciences. Flow cytometry analyses were performed 
using FlowJo 10.1, and statistical analyses were performed using 
Prism 6.
For sorting of cell populations for RNA-Seq, BMNCs were 
isolated as described above. Splenocytes were isolated as follows: 
spleens were homogenized in a 40-µm strainer using the blunt 
end of a 3-mL syringe. The homogenate was washed with cRPMI, 
and red blood cells were lysed using ACK buffer from Lonza. 
Cells were then washed and counted. CD8+ T cells were isolated 
from spleen and BMNCs using negative selection columns from 
R&D systems. The purified CD8+ T  cells were then incubated 
with anti-CD103 antibodies according to the protocol described 
above. Cells were suspended at a concentration of 3 × 106 cells/
mL and then sorted using a FACS Aria from BD Biosciences. Cell 
sorting was performed at the Institute for Integrative Genome 
Biology at UC Riverside.
In Situ immunofluorescent staining
Immediately following excision, sagitally bisected brain tissue was 
flash-frozen in a bath of isopentane cooled with dry ice. Frozen 
organs were then put into a standard Tissue-Tek cryomold, filled 
with optimal cutting temperature solution (also from Tissue-
Tek), put on dry ice, and subsequently stored at −80°C. Serial 
sections of 12 µm were prepared on a standard Cryostat machine 
(LEICA/CM1850). For in situ immunofluorescent staining, fro-
zen tissue sections were fixed in 75% acetone/25% ethanol and 
then blocked for 10 min in 10% donkey serum prior to staining. 
For the primary antibody incubation, conjugated anti-mouse 
CD8 and CD103 were added to three panels containing anti-
mouse biotinylated E-cadherin, anti-mouse laminin, or anti-T. 
gondii. Antibodies against CD8, CD103, and E-cadherin were 
from eBioscience, antibodies against laminin from Cedarlane 
Laboratories, and anti-Toxoplasma from Abcam. The sections 
were incubated for 3 h at room temperature. After washing, the 
sections were incubated for 1 h at room temperature with appro-
priate secondary antibodies (streptavidin for anti E-cadherin). 
Samples were mounted in ProLong Gold with DAPI (Invitrogen) 
for nuclear counterstaining. Images were collected on either a 
Leica DMI 6000B epifluorescent or a Leica SP5 scanning confocal 
microscope (Leica Optics), and data were analyzed and quanti-
fied using Volocity 6.1 (Perkin-Elmer).
rna-seq analysis
To obtain sufficient RNA for analysis, CD8 T cells were isolated 
from pooled leukocytes of brain and spleen of at least n = 5 mice. 
This was repeated to obtain four trials to serve as biological repli-
cates in analysis. The isolated CD8 T cells were sorted according to 
expression of CD103, and RNA was extracted from sorted groups 
using an RNeasy Mini Kit from Qiagen. Multiplexed cDNA 
libraries were generated, which included brain CD103+, brain 
CD103−, spleen CD103+, and spleen CD103− CD8 T  cells. Of 
the four trials, libraries of sufficient quality for sequencing could 
not be generated for two brain CD103+ samples and one brain 
CD103− sample. RNA concentration and quality were analyzed 
by running an RNA Nano chip on an Agilent 2100 Bioanalyzer. 
mRNA was enriched using a RiboGone Mammalian kit from 
Clontech. cDNA libraries were generated using a SMARTer 
stranded RNA-Seq kit, also from Clontech. Concentration and 
quality of libraries were measured with a High Sensitivity DNA 
chip (Agilent). The resulting libraries were multiplexed, and 
single-end 50 bp sequencing was performed at the UC Riverside 
Genomics Core facility using the Illumina HiSeq 2500. After 
demultiplexing and QC of the resulting FASTQ files, alignment 
and differential gene expression analysis were performed with 
the systemPipeR workflow1 (30). Quality control and trimming 
were conducted using FastQC2 and Trim Galore,3 respectively. 
The reads were then aligned to the mouse genome using Tophat2 
(31), and transcripts per gene were counted using GenomicRanges 
package in R (32). Differential gene expression analysis was 
performed following TMM normalization using edgeR (30, 33). 
MetaCore software (Thomson Reuters) was used for functional 
enrichment analysis. To conduct functional enrichment analysis, 
only DEGs with a fold change (FC) >2 and FDR <5% were used. 
We further excluded genes with very low counts by only select-
ing gene with a mean reads per kilobase of transcript per million 
mapped reads (RPKM) >1. RPKM served as a normalized value 
for read count and was obtained via GenomicRanges.
Microarray analysis
Microarray data from the studies by Wakim et al. and MacKay 
et al. were obtained from the NCBI Gene Expression Omnibus 
database under accession number GSE39152 (25) and GSE47045 
(26). Differential gene expression analysis was conducted using 
GEO2R. Genes with a corrected p < 0.05 were used for subse-
quent analyses, including functional enrichment analysis. For 
the Wakim et al.’s data, differential gene expression analysis was 
conducted between brain CD8+ CD103+ (n = 5) and brain CD8+ 
CD103− (n = 3) samples. For MacKay et al. data, differential gene 
expression analysis was conducted between skin TRM (n = 3) and 
spleen TCM plus spleen TEM (n = 6) samples.
restimulation assay
Brain mononuclear cells were collected from mice by 5  weeks 
postinfection and incubated for 6 h in complete T cell media (86% 
DMEM, 10% FBS, 1% penicillin/streptomycin, 1% l-glutamine, 
1% NEAA, 1% sodium pyruvate, <0.01% β-mercaptoethanol) 
with 10  µg/mL BFA. Cells were treated with 10  µg/mL 
αCD3/αCD28 (BD Biosciences) antibody or media alone. After 
restimulation, cells were collected, and surface staining was 
performed as described above. Intracellular cytokine staining 
was performed with the FoxP3/transcription factor staining 
buffer kit from eBioscience. Antibodies against IFN-γ and TNF-
α were obtained from eBioscience. Flow cytometry analyses 
were performed using FlowJo 10.1, and statistical analyses were 




FigUre 1 | Kinetics and specificity of cD103+ cD8 T cells in the Toxoplasma-infected brain. Brain mononuclear cells harvested from Toxoplasma 
gondii-infected mice at indicated time points and gated on live CD3+ CD8+ cells. (a) Numbers indicate the proportion of CD69+ CD103+ and CD69+ CD103− CD8 
T cells in the brain at the indicated time points. (B) Absolute cell counts for the data are shown in panel (a). (c) Percentage of dextramer+ CD8 T cells in the brain.  
(D) Percentage of SIINFEKL dextramer+ CD8 T cells expressing CD103. Data from week 12 postinfection. Numbers indicate average ± SEM of three biological 
replicates for each time point. Significance was determined using two-way ANOVA with multiple comparisons post test. ****p < 0.0001. Data are representative of 
two independent experiments with similar results.
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resUlTs
Kinetics and Distribution of cD103+ cD8  
T cells in the Toxoplasma-infected Brain
TRM are defined as a persisting population of T cells that remain 
localized to the tissue, that is, non-recirculating. To determine 
whether such a population exists in the brain during chronic T. 
gondii infection, we investigated whether a stable TRM phenotype 
could be observed across the course of infection and whether 
such a phenotype would localize to the parenchyma. Therefore, 
we enumerated the distribution and kinetics of CD8 T cells in the 
brain expressing the residency markers CD103 and CD69. There 
are no T cells in a naïve uninfected brain (1, 34); however, by 
2 weeks postinfection, representing the late acute stage, there is a 
small proportion (2 ± 0.4%) of CD8 T cells exhibiting a CD103+ 
CD69+ phenotype. This population significantly increases 
(p < 0.0001) over the course of infection, and at the late chronic 
stage (12 weeks postinfection), 38 ±  1% of CD8+ T  cells were 
observed to be positive for CD103 and CD69 (Figures 1A,B). 
Thus, by the late stages of chronic infection, this phenotype 
forms a substantial percentage of the CD8 subset in the brain 
relative to all other phenotypes contained in the CD103− group. 
In the periphery, CD103+ cells are observed to accumulate in 
the spleen and lymph node over time; however, such cells 
did not express CD69 in significant proportions (Figure S1 
in Supplementary Material) and are more transcriptionally 
consistent with a quiescent/naïve population (Figure S2 in 
Supplementary Material) (35). In contrast, the brain has no 
population of CD103+ CD8 T  cells that do not express CD69 
(Figure 1A), and therefore, the use of this marker for subsequent 
analysis was redundant.
Previous work has suggested that the majority of T  cells in 
the brain are specific for the parasite, and there is little evidence 
of a bystander population (36). However, to rule out the pos-
sibility that CD103-expressing cells are not directly responding 
to parasite infection, we used parasites engineered to express 
ovalbumin along with ovalbumin-specific (SIINFEKL) MHC I 
dextramer (29, 36) to test the antigen specificity of this popula-
tion. At 12 weeks postinfection, approximately, 3% of CD8+ cells 
in the brain are bound by the SIINFEKL dextramer, a significant 
proportion of which express CD103 (Figure  1C). These data 
do not definitively establish that all CD103+ CD8 T cells in the 
brain are parasite specific nor does it indicate the full repertoire 
of parasite antigens to which CD103+ CD8 T cells could respond. 
Nevertheless, it does support the view that brain CD103+ CD8 
T cells are not simply a bystander population and is consistent 
with the previous work demonstrating that retention of T  cell 
populations in the brain requires cognate antigen at this site 
(Figure S7 in Supplementary Material) (36, 37).
To determine whether CD103+ CD8 T cells localize to distinct 
environments within the brain, we used in situ immunofluores-
cent staining. Expression of CD103 by CD8 T cells is observed 
FigUre 2 | Distribution of cD103+ cD8 T cells in the Toxoplasma gondii-infected brain. Immunofluorescent staining in situ for CD8 and CD103 in 
representative sagittal section-infected brain at 5 weeks postinfection. (a) E-cadherin staining in choroid plexus of lateral ventricle, 40× magnification, zoomed in.  
(B) Laminin staining for vasculature of frontal cortex, 40× magnification, zoomed in. (c) T. gondii staining in the frontal cortex, 25× magnification, zoomed in. All 
images are representative of n = 3 biological replicates at 5 weeks post infection. White arrows indicate examples of staining positive for both CD8 and CD103. 
Scale bar indicates 20 µm.
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at entry points to the brain, including the choroid plexus, where 
it associates with the CD103 ligand E-cadherin (Figure 2A). In 
addition, this population can be found within the perivascular 
space (Figure  2B) and within the parenchyma, despite little 
expression of E-cadherin at these sites (38). Finally, this popula-
tion can be observed in proximity to cysts and individual para-
sites (Figure 2C). Quantification of the distance of CD103+ cells 
from cysts was highly variable (80–160 µm), and there was no 
correlation between cyst and CD103+ cell number (Figure S3 in 
Supplementary Material).
Together these data indicate that a population of CD103+ 
CD8 T cells can be observed throughout the chronic stage and 
form a substantial proportion of the CD8 subset in the infected 
CNS. In situ immunofluorescent staining revealed that CD103 
expression is not confined to a certain area of the brain or specifi-
cally localized to the regions of infection. Our observation that 
CD103+ CD8 T  cells are present within the perivascular space 
suggests that this phenotype may be acquired before entry into 
the parenchyma. Together, these data raised the possibility that 
CD103 did not define a homogenous population of T cells within 
the brain but rather a functionally diverse set of cells having in 
common expression of CD103.
cD103+ cD8 T cells exhibit a Distinct 
Transcriptional Profile relative to Other 
cD8 T cells in the Brain and Periphery
The heterogeneity of infiltrating T cells during chronic infection 
(8, 36, 39, 40) required we exclude the possibility of CD103 
expression masking a group of functionally and phenotypically 
diverse cells that are not TRM. Furthermore, expression of CD103 
is not the limiting phenotype for TRM, that is, a memory T cell can 
be resident (non-recirculating) without expressing CD103 (13). 
To address whether CD103 defines a transcriptionally distinct 
population within the brain that is uniquely characteristic of TRM, 
RNA-Seq analysis was performed on sorted cells from infected 
mice at 4 weeks postinfection.
Three comparisons between CD8+ subsets were carried 
out (Figure 3A). The first comparison, brain CD103+ to brain 
CD103−, specified whether CD103 defined a transcriptionally 
distinct population within the brain. The second comparison, 
brain CD103+ to spleen CD103+, specified whether CD103 
defined a transcriptionally distinct CD8 T  cell population 
when compared to a putatively naïve peripheral population 
of the same phenotype. Finally, the brain CD103+ to spleen 
CD103− comparison specified whether CD103 defined a 
FigUre 3 | Transcriptional characteristics of brain cD103+ cD8 T cells. CD8 T cells were isolated from the brain and spleen of chronically infected mice and 
sorted according to CD103 expression. (a) Differentially expressed genes (DEGs) for the three indicated analyses. Numbers indicate combined upregulated and 
downregulated DEGs with fold change >2 and FDR <5%. (B) PCA plot for normalized read counts (reads per kilobase of transcript per million mapped reads) for all 
samples.
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transcriptionally distinct population of CD8 T  cells when 
compared to a putatively activated peripheral population. The 
comparison of brain CD103+ to spleen CD103− yielded the 
greatest number of DEGs (2,350) (Figure  3A). This provided 
preliminary evidence that the brain CD103+ CD8 T cell group 
is transcriptionally dissimilar to both local and peripheral CD8 
T cells. To confirm these data, principal component analysis was 
performed to determine the variance in RPKM across all groups 
(Figure  3B). The resulting plots demonstrate that the brain 
CD103+, brain CD103−, spleen CD103+, and spleen CD103− 
populations are transcriptionally distinct from each other. 
PC1 appears to define the organ, spleen versus brain, whereas 
PC2 appears to define CD103 expression. PC1 had a loading of 
12.90, and PC2 had a loading of 14.14. The most variable gene 
in PC1 was transthyretin, whereas the most variable gene in 
PC2 was S1pr5 (Figure S4 in Supplementary Material). These 
data lend support to CD103 expression defining a distinct and 
homogenous population of CD8 T cells within the chronically 
infected brain.
cD103+ cD8 T cells exhibit a Distinct 
Transcriptional Profile relative to Brain 
cD103− cD8 T cells that is consistent 
with TrM
Next, DEGs were analyzed between CD103+ CD8 T  cells and 
CD103− CD8 T  cells within the brain. Functional enrichment 
analysis revealed that the DEGs enriched to GO terms such as 
cell migration, proliferation, and differentiation (Figures 4A,B). 
These processes are critical aspects of T cell response to infection, 
T cell signaling, and activation. In addition, these DEGs had sig-
nificant overrepresentation of notable disease terms—“RNA virus 
infection” (Figures 4A,C) and “arteriosclerosis” (Figures 4A,D). 
In support of the view that this is a memory population, the 
terminal differentiation marker Klrg1, expression of which 
defines terminally differentiated effector cells, is downregulated 
in the brain CD103+ population (FC = −3.5), whereas Il-7r, a 
receptor that defines memory cells is upregulated (FC =  2.1) 
(Figures 4C,E). Furthermore, consistent with tissue residency is 
FigUre 4 | Distinct transcriptional profile of brain cD103+ cD8 T cells relative to brain cD103− cD8 T cells. (a) After conducting differential gene 
expression analysis between brain CD103+ and brain CD103− CD8 T cells, the genes with a fold change >2, FDR <5%, and mean RPKM >1 were input into 
MetaCore for functional enrichment. Of the 239 genes input, the following terms with FDR <5% were extracted from the categories “Disease by Biomarker” and 
“GO Process.” (B) Heatmap of genes under GO process term “Positive regulation of cell migration.” (c) Heatmap of genes under Disease term “RNA virus.”  
(D) Heatmap of genes under enrichment term “Arteriosclerosis.” Individual replicates in heatmap are pooled from n = 5 mice. Values in legend are scaled values 
representative of RPKM. Red indicates a highly expressed gene, and blue indicates a gene with a low expression value. (e) Table of fold changes and false 
discovery rate for genes relevant to tissue residence and memory phenotype. (F) Flow cytometry for differential expression of S1PR1 and KLRG1.
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the downregulation of Klf2 (FC = −2.5) and S1pr1 (FC = −4.4) 
in the brain CD103+ population (Figures  4B–E), inhibiting 
recirculation of cells back to lymphoid organs (Schenkel and 
Masopust). To validate differential expression, flow cytometry of 
BMNCs was conducted. This confirms downregulation of both 
S1PR1 and KLRG1 at the protein level in CD103+ CD8+ T cells 
(Figure 4F). The percentage of CD103− S1PR1+ CD8 T cells is 
approximately threefold higher that of the CD103+ S1PR1+ subset 
(0.88 versus 3.32%) (Figure  4F). A total of 37.50% of CD103− 
CD8 T cells were KLRG1+, whereas 1.05% of CD103+ CD8 T cells 
were KLRG1+ (Figure 4F).
Additional changes of interest in the brain CD103+ popula-
tion included upregulation of the co-inhibitory receptor Ctla4 
(FC =  2.14) and the transcription factor Irf4 (FC =  2.1) and 
downregulation of the transcription factor Atf3 (FC = −2.6) 
(Figures 4C–E). Ctla4 is among the first co-inhibitory recep-
tors to be expressed and could provide evidence of increased 
antigen engagement in this subset (41). Although several 
co-inhibitory receptors were upregulated in the brain CD103+ 
group compared to the spleen CD103+ group, including Pdcd1 
(FC = 77.7), Lag3 (FC = 9.2), and Tigit (FC = 27.7) (not shown), 
only Ctla4 was uniquely upregulated relative to other CD8 
T cells in the brain.
A set of genes associated with extracellular adhesion and 
migration were upregulated in the brain CD103+ population, 
including Cdh1 (E-cadherin, FC  =  2.9), Adam8 (FC  =  2.3), 
Swap70 (FC = 2.8), Sema6d (FC = 3.7), and Lpar3 (FC = 13.9) 
(Figures 4B,E). Excluding Sema6d, these are novel upregulated 
genes in T cells (42–45). Both Sema6d and the E-cadherin gene 
were also upregulated relative to peripheral spleen CD8 T cells 
(both CD103− and CD103+), supporting the possibility that these 
genes are unique determinants of residency for the brain CD103+ 
population in our model (Figure S5 in Supplementary Material). 
This was also the case for the downregulated genes S1pr1 and Klf2 
(Figure S5 in Supplementary Material).
TrM from the Toxoplasma-infected Brain 
share a core set of Differentially 
expressed genes with TrM from Vesicular 
stomatitis Virus (VsV)
The original studies of TRM in the brain by Wakim and colleagues 
included microarray analysis to generate a transcriptional profile 
of TRM in a VSV model of acute and resolved brain infection (25). 
We compared DEGs from this model with the RNA-Seq data 
generated in our chronic model, focusing specifically on brain 
CD103+ CD8 T cells relative to brain CD103− CD8 T cells. The 
results of our Venn analysis reveal a set of 27 genes (~5%) com-
mon to both transcriptional profiles (Figure 5A). S1pr1, Klf2, and 
Adam8 are contained within this set, suggesting similar mecha-
nisms of residency between the two models (Figure 5B). Swap70 
and Eomes are also represented in this group. A remaining 70 
genes are unique to VSV, and a remaining 393 genes are unique 
to T. gondii. The top enrichment terms for these sets of genes were 
“immune system process” and “cell adhesion” (Figures  5C,D, 
respectively). When our data were compared to data from skin 
TRM generated from HSV infection (26), we observed a similar 
set of 33 differentially expressed genes, comprising 4.1% of the 
total DEGs (Figure S6 in Supplementary Material). Although 
the majority of differentially expressed genes in each model were 
unique to the model, a core profile of genes associated with tis-
sue residency was common to all models (Figure 5; Figure S6 in 
Supplementary Material).
cD103+ cD8 T cells Produce a 
significantly greater Percentage of Pro-
inflammatory cytokines
Several cytokines and receptors including Tgfb3, Il1a, Il1b, Il22, 
and Csf1r are downregulated in brain CD103+ CD8 T cells rela-
tive to brain CD103− CD8+ T cells (Figures 4B–D). The TGF-β 
receptor was upregulated (FC =  2.75) in brain CD103+ CD8 
T cells, consistent with previous reports of the requirement for 
TGF-β in generation of this population (46, 47). Notably, the pro-
inflammatory cytokine Tnf is significantly upregulated in CD103+ 
CD8 T cells (FC = 2.5 relative to brain CD103−) (Figures 4B–D; 
Figure S5 in Supplementary Material). TRM are reported to pro-
duce this cytokine although their ability to do so relative to other 
CD8 T  cell subsets has not been previously validated via flow 
cytometry (16, 25, 26).
To validate and confirm the increase in Tnf gene expression in 
the CD103-expressing cells, BMNCs from chronically infected 
mice were restimulated and production of IFN-γ and TNF-α was 
compared between the CD103+ and CD103− subsets. The propor-
tion of CD103+ T  cells producing both IFN-γ and TNF-α was 
significantly greater than cells not expressing CD103 (19.6 ± 5.3 
versus 9.3 ±  3.7%; p <  0.01) (Figures  6A,B). Furthermore, of 
CD103+ CD8 T cells expressed more total TNF-α and more total 
IFN-γ on a per cell basis than their CD103− counterparts (for 
IFN-γ: 3,824 ±  787% versus 3,208 ±  746 MFI; p <  0.05) (for 
TNF-α: 8,778 ±  2,165% versus 5,966 ±  1,171 MFI; p <  0.05) 
(Figures 6C,D). Since both TNF-α and IFN-γ are critical for pro-
tection against toxoplasmic encephalitis (TE) (5, 48), these data 
suggest that the CD103+ TRM population contributes to protection 
within the brain at the chronic stage.
DiscUssiOn
These data support the conclusions that (1) CD103+ CD8 T cells in 
the brain during chronic T. gondii infection are a transcriptionally 
distinct population, (2) this population exhibits transcriptional 
signatures characteristic of TRM, and (3) this population has a dis-
tinct contribution to the pro-inflammatory protective response 
to the parasite.
Expression of CD103 can define a resident memory T cell, yet 
the TRM phenotype is not restricted to CD103 expression, nor is 
CD103 expression exclusive to this subset (13, 47, 49–51). This is 
seen in our data with flow cytometry and immunohistochemistry 
data revealing expression of CD103 by CD4+ T cells and dendritic 
cells in the Toxoplasma-infected brain and CD8+ T cells (Figure 2; 
Figure S7 in Supplementary Material and data not shown) (52, 53). 
However, our data suggest that within brain, CD8+ T cells expres-
sion of CD103 does indeed represent a population of TRM cells 
that are not restricted to the E-cadherin-expressing endothelial 
FigUre 5 | comparison of tissue resident memory T cells (TrM) from acute vesicular stomatitis virus (VsV) to Toxoplasma gondii. Microarray data from 
the study by Wakim et al. were obtained and analyzed via GEO. (a) Venn diagram of DEGs in T. gondii and VSV (25) for the brain CD103+ CD8 T cells relative to 
brain CD103− CD8 T cells. (B) Comparison of fold changes for the 27 differentially expressed genes common to both models. RNA-Seq DEGs were determined 
according to the following criteria: fold change >2, FDR <5%, p < 0.05, and mean RPKM >1. Microarray DEGs were significant if the p value and adjusted p value 
were less than 5%. (c) Results of enrichment analysis for DEGs unique to microarray analysis of TRM in VSV. (D) Results of enrichment analysis for DEGs unique to 
RNA-Seq analysis of TRM in T. gondii infection.
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cells of the choroid plexus but are also found in parenchymal and 
extraparenchymal spaces, independently of cyst location (24, 38). 
Previously, effector T cells have been postulated to be essential 
for control of chronic infection, although the presence of a TRM 
population is in keeping with the requirement to continuously 
keep cyst reactivation in check.
The reason for CD103 defining a resident memory population 
has not been addressed, and perhaps this is even less clear when 
brain tissue expresses very little of this integrin’s primary ligand, 
E-cadherin (38). The expression of N-cadherin is highly prevalent 
in the brain, and CD103 has the potential to bind to this cadherin 
instead (unpublished data). However, our observation that the 
E-cadherin gene is upregulated in the CD103+ population sug-
gests that residency could be mediated by homotypic pairings 
within the CD103+ population. Alternatively, our data would 
support the concept that dendritic cells serve as a binding partner 
for CD103+ CD8 T cells and mediate residency via formation of 
the immunological synapse. This could occur via the expression 
of E-cadherin on brain-infiltrating dendritic cells (54) or, given 
that our brain TRM upregulate Sema6d, via binding to plexins on 
dendritic cells (43, 44). Independent of cell–cell interactions, 
CD103+ cells also upregulate Adam8. This gene encodes for a 
metalloprotease implicated in cell-matrix adhesion in human 
PBMCs and may serve as an additional residency determinant in 
the brain TRM population (43). In addition, this gene could play 
a role in facilitating cytokine shedding (55) and thus provide a 
mechanistic basis for the increased cytokine production in this 
population.
FigUre 6 | Production of pro-inflammatory cytokines in cD103+ cD8 T cells. Brain mononuclear cells from chronically infected mice were restimulated with 
α-CD3/α-CD28 antibodies for 6 hours and intracellular cytokine staining was performed. Data were gated on live CD3+ CD8 T cells and then split into CD103+ and 
CD103– subsets for subsequent analysis. (a) Representative flow plot indicating percentage of restimulated CD103+ and CD103– CD8 T cells producing IFN-γ and 
TNF-α. Numbers indicate mean percentage ± SEM of n = 5 biological replicates. (B) Paired data plot of the data shown in (a). (c) Geometric MFI of IFN-γ 
production comparing CD103+ to CD103– CD8 T cells subsets. (D) Geometric MFI of TNF-α production for the same comparison. Significance was determined 
using a paired two-sample t-test. *p < 0.05, **p < 0.01; p values are one tailed. Data are representative of two independent experiments with similar results.
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TGF-β-dependent upregulation of CD103 plays a crucial co-
stimulatory role in facilitating TCR-mediated cytokine secretion 
for tumor specific CD8+ T cells (47). The role of TGF-β in the 
generation and maintenance of CD103+ TRM has been previously 
reported (24). Our transcriptional data suggest that CD103− CD8+ 
T cells may serve as a source of TGF-β, and this is strengthened 
by the concurrent upregulation of Atf3 in this population (56).
Consistent reports show a dependence on dendritic cell inter-
actions for the priming of or the retention of TRM, and our data 
are supportive of this (51, 57). This may extend to other models 
and tissues, particularly in the context of chronic infections. TRM 
are observed to accumulate in cases of non-specific inflamma-
tion, but during latent viral infections, there is speculation that 
survival of CD103+ CD8 T cell populations within neural tissues 
is uniquely dependent on antigen presentation (24, 26, 46). A 
direct comparison of acute and chronic mucosal LCMV infection 
indicates that chronic viral infection can promote the accumula-
tion of CD4+ TRM in non-lymphoid tissues and upregulation of 
non-lymphoid tissue homing markers such as CXCR4 (58). This 
is in agreement with our data demonstrating the accumulation 
of TRM in the brain over the course of infection. Finally, in a vac-
cinia virus model of acute skin infection, cognate antigen is not 
required for recruitment of CD8+ TRM per se, but the local antigen 
profile influences the degree of accumulation and TCR repertoire 
of such TRM (59). Taken together, these and our data support local 
antigen presentation as a cue for long-term maintenance and 
accumulation of TRM.
In addition to genes involved in residency determination, 
we also observed differentially expressed genes that suggest 
mechanisms of motility within the brain for CD103+ CD8 T cells. 
These include the GPCR Lpar3 and the guanidine exchange fac-
tor Swap70, which are upregulated (42, 45). Swap70 expression, 
although typically associated with B cells, has also been shown 
to initiate membrane ruffling in fibroblasts (42). Although Lpar3 
expression has not been reported in T cells, it has been reported 
to mediate motility and proliferation in cancer cells and therefore 
could play an analogous role in tissue-resident T cells (45).
Although the transcriptional profile generated during T. gon-
dii infection is distinct to the transcriptional profile generated 
during VSV, the differentially expressed genes shared between 
the two profiles are consistent with a TRM population (25) and 
suggest that a TRM subset also exists during chronic infection in 
the CNS. Our study also demonstrates an important role for these 
cells in producing effector cytokines. Stimulation of CD103+ 
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T  cells compared to CD103− led to an increase in IFN-γ and 
TNF-α production. Although TRM have been reported to produce 
TNF-α, our results suggest that they have a greater capacity to 
produce this cytokine, compared to non-CD103+ T cells in the 
brain (16, 25). TNF-α is crucial to prevent progression of TE 
(48, 60, 61). Mice treated with anti-TNF-α antibodies succumb 
to primary infection (48), and mice lacking TNF-α receptors 
exhibit necrosis of brain tissue due to parasite reactivation 
(60, 61). More recently, a study enriching TRM in the gut through 
depletion of circulating T cells demonstrate a critical function 
of TNF-α in the recruitment and activation of dendritic cells 
(16). This could serve as an alternate/additional mechanism by 
which TRM are able to participate in the protective response to 
infection via production of TNF-α and recruitment of innate 
and/or antigen-presenting cells. Although the contribution of 
this subset to overall TNF-α production in the BMNC compart-
ment is small, the significantly increased capacity to produce 
this cytokine relative to other CD8 T cells suggests that it may 
be optimized to respond in a robust fashion to inflammatory 
microenvironments within the brain.
The increased production of IFN-γ in brain CD103+ CD8 
T cells relative to other CD8 T cells in the brain also points to a 
role for TRM in protection against TE. This stimulation occurred 
by 5 weeks of infection. At this point, peak recruitment of effector 
cells has passed, and there is now a considerable population of 
PD-1hi exhausted effector cells that have a reduced capacity for 
IFN-γ production (8, 36, 62). Thus, the role of TRM as a source 
of cytokine production has important functional implications. 
IFN-γ is required for the protective response to chronic T. gondii 
infection, serving to activate microglia, astrocytes, and mac-
rophages, to control parasite replication while also playing a role 
in T cell recruitment (5, 63–65). Overall, the CD103+ population 
has enhanced the production of critical effector cytokines and 
indicates that this subset of CD8+ T cell remains activated in the 
presence of ongoing inflammation unlike other subsets in the 
infected brain.
As expected with a TRM phenotype, there is downregulation 
of the transcription factor Klf2 that promotes retention within 
the tissue through downregulation of S1pr1. Our data show 
downregulation of the transcription factor Klf3 in addition 
to Klf2. KLF3 has the potential to play numerous roles in a 
resident population. KLF3−/− mice show significantly increased 
production of galectin-3, a mediator of diverse actions including 
chemotaxis and inflammation (66). Thus, the downregulation of 
KLF3 further supports brain CD103+ T cells being non-circu-
lating or a highly pro-inflammatory population. It is clear that 
CD103− T cells in the brain upregulate a potent array of pro- and 
anti-inflammatory cytokines; therefore, it would be overly sim-
plistic to state that CD103+ T cells in the brain are the sole pro-
inflammatory population. Nonetheless, the transcriptional data 
suggest that this is a primary role for this subset. An increased 
production of pro-inflammatory cytokines is consistent with the 
view that the CD103+ population is a T cell memory population, 
and increased expression of Adam8 along with the upregulation 
of Ctla4 may reflect increased TCR engagement in this subset 
(41, 55). Indeed, this potentially fits a model where residency 
is maintained by continued antigen recognition in the brain 
via dendritic cells or other APCs, and this in turn upregulates 
cytokine production.
An important distinction between our model and others where 
TRM have been studied is the persistence of antigen within the 
brain where such antigen is continuously visible to the immune 
system. Previously published data using adoptive transfer of 
OVA-specific CD8+ T cells show that these cells are accumulated 
only in the brain when the infection was conducted with OVA-
expressing parasites (36). This along with the data published 
here indicates that the CD103+ population is parasite specific. 
Our data are supportive of previous studies in chronic infection 
demonstrating exhaustion of the entire brain CD8 T cell popula-
tion in the form of upregulation of several co-inhibitory receptors 
(Ctla4, Pdcd1, Lag3, and Tigit) relative to spleen CD103+ CD8 
T  cells (8, 36, 62). In addition, Ctla4 is further upregulated in 
CD103+ CD8 T cells relative to other CD8 T cells in the brain, 
suggesting an increased engagement with antigen in this subset 
as alluded to previously.
The transcription factors Hobit and Blimp-1 have been 
recently reported to be specifically required for the development 
of tissue-resident memory lymphocytes in the skin, gut, liver, 
and kidney (67, 68). Although we did not observe evidence of 
differential expression for these transcription factors in our data 
set, it is possible that the formation of tissue-resident memory 
T cells within the brain and other neural tissues may follow a 
divergent developmental pathway compared to other tissues. 
This could be especially true in an environment of a continuous 
inflammation with persistent antigen. In our data, we observe 
upregulation of the transcription factor Irf4. Expression of this 
gene is dependent on the strength of the initial TCR stimulus 
and is required for sustained proliferation and expansion of 
CD8 T  cells in the context of influenza virus infection (69). 
Expression of this transcription factor by the brain CD103+ 
population could be particularly beneficial in the context of a 
chronic infection.
Support for the unique heterogeneity and complexity of the 
T cell population during chronic T. gondii infection is provided by 
the recent characterization of the TINT population (9). Such cells 
serve as a pool from which to quickly generate effector T cells 
during persistent infection and serve as additional evidence that 
chronic infection produces unique T cell phenotypes compared 
to acute infections. We envision a model in which a precursor 
population gives rise to both TRM and TINT independently. Our 
data suggest that TRM may play a significant part in the protective 
response to the parasite, which would be a distinct role of the 
TINT population.
It is worthwhile to note that we have reported a substantial 
population of CD103+ CD69-CD8 T cells progressively accumu-
lating in the secondary lymphoid organs that our data suggest is 
quiescent. Naïve CD8 T cells are capable of expressing CD103 at 
intermediate levels, but must downregulate CD103 upon activa-
tion (26). Although there is precedence for TRM in secondary lym-
phoid organs during LCMV infection, such cells are uniformly 
CD69+ and do not express CD103 (21). Therefore, the accumula-
tion of CD103+ CD69− cells in secondary lymphoid tissue most 
likely represents a naïve population. Nonetheless, our data do not 
exclude the possibility of TRM in other non-lymphoid peripheral 
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organs. In addition to the brain, the parasite can localize to the 
skeletal muscle and eye during chronic phase of infection (70), 
and muscle-infiltrating TREG populations are reported to play a 
critical role in tissue repair at this site (71). It is possible that TRM 
can play a similar role during chronic infection at additional sites 
to the brain.
Taken together, these data provide insight into understanding 
the coordination of effector and memory T cell responses in the 
context of a chronic localized protozoan infection in the brain. 
We show that the expression of CD103 by brain-infiltrating CD8 
T  cells defines a transcriptionally distinct population during 
chronic T. gondii infection. Furthermore, we show that this popu-
lation is transcriptionally consistent with tissue-resident memory 
T  cells and has an increased capacity for pro-inflammatory 
cytokine production relative to other CD8 T cells in the brain. 
Therefore, our data indicate a need for further investigation into 
a unique protective role for TRM during chronic infection.
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FigUre s1 | cD103 expression kinetics and specificity of the cD8+ T cell 
subset in the peripheral secondary lymphoid organs. (a) CD103+ CD69+ 
CD8 T cells in the spleen and lymph node. (B) Percentage of dextramer+ CD8 
T cells in the spleen. Data are representative of two independent experiments 
with similar results.
FigUre s2 | Transcriptional profile of spleen cD103+ population relative 
to spleen cD103− population. (a) DEG for the specified comparisons.  
(B) Venn diagram for DEG for each specified comparison. Two hundred ninety 
genes common to the spleen CD103+/spleen CD103− and brain CD103+/spleen 
CD103+ were input into MetaCore. (c) Genes under categories “JAK/STAT 
pathway and inflammation” and “modulation of effector T cell function” were 
merged into one heatmap. (D) Heatmap of the same set of genes as in panel  
(c) for the brain CD103+ and spleen CD103+ groups. Individual replicates in 
heatmap were pooled from n = 5 mice. Values in legend are scaled values 
representative of reads per kilobase of transcript per million mapped reads 
(RPKMs). Red indicates a highly expressed gene, and blue indicates a gene with 
a low expression value. DEG for each comparison were determined according to 
the following criteria: fold change >2, FDR <5%, p < 0.05, and mean RPKM >1.
FigUre s3 | Quantification of distance from cysts to cD8+ cD103+.  
(a) Schematic of fields of view counted in a representative slice. (B) Total number 
of cysts versus total number of CD8+ CD103+ T cells for each field of view 
analyzed. (c) Distance to closest cyst in the field of view for each positive cell. 
Data are representative of two independent experiments with similar results.
FigUre s4 | genes contributing to variability in Pca plots. (a) Fifty most 
variable genes in PC1. (B) Fifty most variable genes in PC2.
FigUre s5 | Transcriptional profile of brain cD103+ cD8 T cells relative 
to spleen cD103+ cD8 T cells. (a) Venn diagram illustrating unique and shared 
DEG for each indicated comparison. (B) Heatmap for a subset of the 42 DEG 
common to all indicated comparisons, shown in panel (a). Individual replicates in 
heatmap were pooled from n = 5 mice. Values in legend are scaled values 
representative of reads per kilobase of transcript per million mapped reads 
(RPKMs). Red indicates a highly expressed gene, and blue indicates a gene with 
a low expression value. DEG for each comparison were determined according to 
the following criteria: fold change >2, FDR <5%, and mean RPKM >1.
FigUre s6 | comparison of tissue-resident memory (TrM) from hsV in 
skin to Toxoplasma gondii. Microarray data from the study by MacKay et al. 
were obtained and analyzed via GEO. (a) Venn diagram of DEG in T. gondii and 
HSV (26) for the brain TRM (n = 3) relative to spleen TCM and TEM (n = 6).  
(B) Comparison of fold changes for the 33 DEGs common to both models. 
RNA-Seq DEG were determined according to the following criteria: fold change 
>2, FDR <5%, p < 0.05, and mean RPKM >1. Microarray DEG were significant 
if the p value and adjusted p value were less than 5%.
FigUre s7 | interaction of brain tissue-resident memory with cD11c+ 
cells in the brain. IHC for interactions between CD103+ CD8 T cells and 
dendritic cells. (a) Frontal cortex, 40×. Red arrow indicates CD103+ CD8 T cell in 
contact with CD11c+ dendritic cell. (B) Zoomed image of area indicated in panel 
(a). Representative image of n = 3 biological replicates. Scale bar indicates 
20 µm.
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